APA (7th ed.) Citation

Nakamura, N., Arai, Y., Kitawaki, T., Jo, T., Mizumoto, C., Kanda, J., . . . Takaori‐Kondo, A. (2023). Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy. British journal of haematology, 200(1), e1-e3. https://doi.org/10.1111/bjh.18504

Chicago Style (17th ed.) Citation

Nakamura, Naokazu, Yasuyuki Arai, Toshio Kitawaki, Tomoyasu Jo, Chisaki Mizumoto, Junya Kanda, Momoko Nishikori, Kouhei Yamashita, and Akifumi Takaori‐Kondo. "Decreased Serum Phosphate Levels Are a Useful Biomarker to Predict Occurrence and Severity of Cytokine Release Syndrome in Chimeric Antigen Receptor T‐cell Therapy." British Journal of Haematology 200, no. 1 (2023): e1-e3. https://doi.org/10.1111/bjh.18504.

MLA (9th ed.) Citation

Nakamura, Naokazu, et al. "Decreased Serum Phosphate Levels Are a Useful Biomarker to Predict Occurrence and Severity of Cytokine Release Syndrome in Chimeric Antigen Receptor T‐cell Therapy." British Journal of Haematology, vol. 200, no. 1, 2023, pp. e1-e3, https://doi.org/10.1111/bjh.18504.